Bio-Rad Laboratories, Inc, a global provider of life science research and clinical diagnostic products, announces the US introduction of the BioPlex 2200 HIV Ag-Ab assay, a fifth-generation multiplex diagnostic test for use on the BioPlex 2200 automated platform. The assay is designed to simultaneously detect and differentiate HIV-1 p24 antigen, antibodies to HIV-1 (groups M and O), and antibodies to HIV-2 in human serum or plasma. It is approved for diagnostic testing, including use with patients as young as 2 years old and pregnant women, and it also can be used for organ donor screening. The BioPlex 2200 System is the first fully-automated, random access multiplex testing system that provides clinical laboratories with the capability to rapidly process multiple individual tests, which are traditionally processed separately. The BioPlex 2200 System conserves patient sample volume, helps consolidate workstations, and simplifies workflow.
www.medlabmag.com uses tracking technologies. The site may also
include cookies from third parties. By continuing to use this website, you consent
to the use of tracking technologies as defined in our
Privacy Policy that can be read by clicking here.